Sol-Gel Technologies 미래 성장

Future 기준 확인 2/6

Sol-Gel Technologies은 연간 수입과 매출이 각각 26.7%와 27.7% 증가할 것으로 예상되고 EPS는 연간 30.5%만큼 증가할 것으로 예상됩니다.

주요 정보

26.7%

수익 성장률

30.5%

EPS 성장률

Pharmaceuticals 수익 성장	24.0%
매출 성장률	27.7%
향후 자기자본 수익률	n/a
애널리스트 커버리지	Low
마지막 업데이트	15 Nov 2024

최근 미래 성장 업데이트

Recent updates

There's Reason For Concern Over Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Massive 209% Price Jump

Dec 24

Will Sol-Gel Technologies (NASDAQ:SLGL) Spend Its Cash Wisely?

Feb 28

Here's Why We're Watching Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Situation

Nov 07

Companies Like Sol-Gel Technologies (NASDAQ:SLGL) Are In A Position To Invest In Growth

Jul 21

Sol-Gel Technologies GAAP EPS of $0.01 beats by $0.11, revenue of $3.5M misses by $1.11M

Aug 04

These Analysts Think Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Sales Are Under Threat

May 17

We Think That There Are Issues Underlying Sol-Gel Technologies' (NASDAQ:SLGL) Earnings

Apr 15

Downgrade: Here's How Analysts See Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Performing In The Near Term

Apr 05

We Think Sol-Gel Technologies (NASDAQ:SLGL) Can Afford To Drive Business Growth

Nov 23

We Think Sol-Gel Technologies (NASDAQ:SLGL) Needs To Drive Business Growth Carefully

Aug 04

Here's Why Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) CEO May Deserve A Raise

Jul 01

Sol-Gel says no FDA notification regarding its marketing application for EPSOLAY

Apr 27

Newsflash: Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Analysts Have Been Trimming Their Revenue Forecasts

Mar 05

We're Not Very Worried About Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Rate

Feb 02

What Type Of Returns Would Sol-Gel Technologies'(NASDAQ:SLGL) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Dec 29

FDA accepts Sol-Gel application for Twyneo

Dec 07

Sol-Gel: Slow And Steady Topical Technology

Nov 19

These Analysts Think Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Sales Are Under Threat

Nov 18

Sol-Gel Technologies EPS beats by $0.09, beats on revenue

Nov 12

수익 및 매출 성장 예측

NasdaqCM:SLGL - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	10	-10	-10	N/A	1
12/31/2025	8	-14	-9	N/A	2
12/31/2024	13	-8	-4	N/A	1
9/30/2024	12	-10	N/A	N/A	N/A
6/30/2024	7	-15	-17	-17	N/A
3/31/2024	2	-23	N/A	N/A	N/A
12/31/2023	2	-27	-18	-18	N/A
9/30/2023	1	-28	N/A	N/A	N/A
6/30/2023	1	-26	-11	-11	N/A
3/31/2023	5	-20	N/A	N/A	N/A
12/31/2022	4	-15	-10	-9	N/A
9/30/2022	25	5	N/A	N/A	N/A
6/30/2022	33	10	-3	-3	N/A
3/31/2022	31	2	N/A	N/A	N/A
12/31/2021	31	3	-8	-8	N/A
9/30/2021	13	-17	N/A	N/A	N/A
6/30/2021	6	-27	-27	-27	N/A
3/31/2021	6	-26	N/A	N/A	N/A
12/31/2020	9	-29	-26	-25	N/A
9/30/2020	11	-29	N/A	N/A	N/A
6/30/2020	13	-28	-20	-19	N/A
3/31/2020	20	-26	N/A	N/A	N/A
12/31/2019	23	-25	-23	-22	N/A
9/30/2019	19	-30	N/A	N/A	N/A
6/30/2019	14	-30	-29	-28	N/A
3/31/2019	6	-32	N/A	N/A	N/A
12/31/2018	0	-32	-25	-23	N/A
9/30/2018	0	-26	N/A	N/A	N/A
6/30/2018	0	-32	N/A	-21	N/A
3/31/2018	0	-32	N/A	N/A	N/A
12/31/2017	0	-32	N/A	-24	N/A
9/30/2017	N/A	-31	N/A	-22	N/A
6/30/2017	N/A	-24	N/A	-22	N/A
3/31/2017	N/A	-22	N/A	N/A	N/A
12/31/2016	N/A	-21	N/A	-18	N/A
12/31/2015	N/A	-10	N/A	-8	N/A

애널리스트 미래 성장 예측

수입 대 저축률: SLGL 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 vs 시장: SLGL 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

고성장 수익: SLGL 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 대 시장: SLGL 의 수익(연간 27.7% ) US 시장( 9.2% 보다 빠르게 성장할 것으로 예상됩니다. 9.2% 연간).

고성장 수익: SLGL 의 수익(연간 27.7% )은 연간 20% 보다 빠르게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: SLGL 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

성장 기업 발견

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2024/12/30 11:42
장 마감 주가	2024/12/30 00:00
수익	2024/09/30
연간 수익	2023/12/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

Sol-Gel Technologies Ltd. 8 애널리스트 중 2 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
null null	BMO Capital Markets Equity Research
Gary Nachman	BMO Capital Markets Equity Research
Raghuram Selvaraju	H.C. Wainwright & Co.

Sol-Gel Technologies 미래 성장

Future 기준 확인 2/6

주요 정보

최근 미래 성장 업데이트

Consensus revenue estimates increase by 13%, EPS downgraded

Consensus revenue estimates decrease by 15%

Consensus revenue estimates decrease by 38%, EPS upgraded

Consensus revenue estimates decrease by 69%, EPS upgraded

Price target decreased by 28% to US$10.50

Consensus revenue estimates decrease by 36%, EPS upgraded

Recent updates

There's Reason For Concern Over Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Massive 209% Price Jump

New major risk - Share price stability

Sol-Gel Technologies Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement

Less than half of directors are independent

Sol-Gel Technologies Ltd., Annual General Meeting, Aug 27, 2024

Sol-Gel Technologies Ltd. Announces Alon Seri-Levy Step Downs from His Position as CEO, Effective December 31, 2024

First quarter 2024 earnings: EPS and revenues miss analyst expectations

New major risk - Revenue and earnings growth

Consensus revenue estimates increase by 13%, EPS downgraded

Full year 2023 earnings: EPS in line with analyst expectations despite revenue beat

Will Sol-Gel Technologies (NASDAQ:SLGL) Spend Its Cash Wisely?

Consensus revenue estimates decrease by 15%

Sol-Gel Technologies Ltd. Announces Resignation of Shmuel Ben Zvi from Board

Now 24% undervalued after recent price drop

Consensus revenue estimates decrease by 38%, EPS upgraded

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Here's Why We're Watching Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Situation

Consensus revenue estimates decrease by 69%, EPS upgraded

Price target decreased by 28% to US$10.50

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Sol-Gel Technologies Ltd. Appoints Sharon Kochan to the Board of Directors

Companies Like Sol-Gel Technologies (NASDAQ:SLGL) Are In A Position To Invest In Growth

Consensus revenue estimates decrease by 36%, EPS upgraded

Co-Founder notifies of intention to sell stock

Sol-Gel Technologies Ltd., Annual General Meeting, Jul 26, 2023

Consensus revenue estimates increase by 42%, EPS downgraded

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus revenue estimates increase by 72%, EPS downgraded

Full year 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorates as stock falls 16%

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to US$12.50

Insufficient new directors

Investor sentiment deteriorated over the past week

Consensus revenue estimates increase by 20%

Price target increased to US$19.00

Price target increased to US$18.00

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Sol-Gel Technologies GAAP EPS of $0.01 beats by $0.11, revenue of $3.5M misses by $1.11M

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Consensus revenue estimates increase by 33%

These Analysts Think Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Sales Are Under Threat

Consensus forecasts updated

Insufficient new directors

Sol-Gel Technologies Announces FDA Approval of EPSOLAY

We Think That There Are Issues Underlying Sol-Gel Technologies' (NASDAQ:SLGL) Earnings

Sol-Gel Technologies Announces the Commercial Availability of TWYNEO

Sol-Gel Technologies Ltd., Annual General Meeting, May 19, 2022

Downgrade: Here's How Analysts See Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Performing In The Near Term

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Consensus revenue estimates fall by 45%

Forecast to breakeven in 2021

Sol-Gel Technologies Announces Positive Update Related to FDA Review Status of EPSOLAY®

Consensus forecasts updated

We Think Sol-Gel Technologies (NASDAQ:SLGL) Can Afford To Drive Business Growth

Price target decreased to US$17.75

Third quarter 2021 earnings released: EPS US$0.056 (vs US$0.38 loss in 3Q 2020)

Second quarter 2021 earnings released: US$0.35 loss per share (vs US$0.31 loss in 2Q 2020)

We Think Sol-Gel Technologies (NASDAQ:SLGL) Needs To Drive Business Growth Carefully

Consensus forecasts updated

Chief Financial Officer notifies of intention to sell stock

Here's Why Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) CEO May Deserve A Raise

Consensus revenue estimates increase to US$17.4m

Consensus forecasts updated

First quarter 2021 earnings released: US$0.18 loss per share (vs US$0.33 loss in 1Q 2020)

Forecast breakeven pushed back to 2024

Sol-Gel Technologies Provides Update on FDA Review of Epsolay®

Sol-Gel says no FDA notification regarding its marketing application for EPSOLAY